Tactical Resources Refiles Q3 Financial Statements and MD&A
Go back to Tactical Resources Refiles Q3 Financial Statements and MD&A| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 33.22 -0.6 (1.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.82 | 52 Week High | $117.12 | |||
| Open | $33.06 | 52 Week Low | $46.52 | |||
| Day High | $33.30 | P/E | N/A | |||
| Day Low | $31.81 | EPS | $-1.97 | |||
| Volume | 1,394,272 | |||||
| (AMEX: USREF) | Delayed: 4.82 +0.17 (3.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.65 | 52 Week High | $ | |||
| Open | $4.82 | 52 Week Low | $ | |||
| Day High | $4.82 | P/E | N/A | |||
| Day Low | $4.82 | EPS | $ | |||
| Volume | 112 | |||||
